NuVasive to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
NuVasive, Inc. (NASDAQ: NUVA) announced its participation in one-on-one investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2-3, 2020. A pre-recorded fireside chat will be available for registered attendees during the week of November 23, 2020, and can be accessed via the Company’s website. NuVasive specializes in spine technology, offering minimally invasive surgical solutions. The Company reported over $1 billion in net sales and operates in more than 50 countries.
- None.
- None.
SAN DIEGO, Nov. 23, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in one-on-one investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2-3, 2020.
A pre-recorded fireside chat with management will be available to registered attendees of the conference during the week of November 23, 2020 and available online from the Investor Relations page of the Company's website at www.nuvasive.com. A replay of the presentation will remain available on the website for 30 days.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes access, implants and fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA® platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-participate-in-the-piper-sandler-32nd-annual-virtual-healthcare-conference-301178234.html
SOURCE NuVasive, Inc.
FAQ
What event is NuVasive participating in on December 2-3, 2020?
When will the pre-recorded fireside chat by NuVasive be available?
Where can I find the replay of NuVasive's conference presentation?
What are NuVasive's primary offerings?
What is NuVasive's reported net sales figure?
